enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ethyl eicosapentaenoic acid - Wikipedia

   en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

   Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL. Further, it is often required to be used with a statin (maximally ...

3. Omega-3 acid ethyl esters - Wikipedia

   en.wikipedia.org/wiki/Omega-3_acid_ethyl_esters

   Omega-3 acid ethyl esters are used in addition to changes in diet to reduce triglyceride levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia. [10] In the European Union and other major markets outside the US, omega-3 acid ethyl esters are indicated for hypertriglyceridemia by itself, or in combination with a statin for people with mixed dyslipidemia.

4. Some Fish Oil Doesn't Help Some Patients in Some Countries - AOL

   www.aol.com/news/2013-05-22-some-fish-oil-doesnt...

   Patients were given 1 gram of omega-3 fatty acids or an olive oil placebo. One gram isn't a whole lot. The recommended dose for GlaxoSmithKline 's prescription-grade fish oil Lovaza is 4 grams.

5. Fish oil - Wikipedia

   en.wikipedia.org/wiki/Fish_oil

   The FDA recommends that consumers do not exceed more than 3 grams per day of EPA and DHA combined, with no more than 2 grams from a dietary supplement. [89] This is not the same as 3000 mg of fish oil. A 1000 mg pill typically has only 300 mg of omega-3; 10 such pills would equal 3000 mg of omega-3.

6. Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA ...

   lite.aol.com/tech/story/0022/20240909/9227242.htm

   DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that new supported and/or funded research on the clinical impact of VASCEPA ® /VAZKEPA (icosapent ethyl) in patients with diabetes and high cardiovascular risk and the anti-Lp(a) oxidation mechanistic effects of eicosapentaenoic acid (EPA) will be presented at the 60 ...

7. Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ...

   lite.aol.com/tech/story/0022/20240822/9218601.htm

   DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded subgroup data from the landmark REDUCE-IT ® cardiovascular outcomes trial with VASCEPA ® /VAZKEPA ® (icosapent ethyl), as well as abstracts showcasing the mechanistic activity of eicosapentaenoic acid (EPA) that will be presented at the ...

8. How Do You Solve a Problem Like Vascepa?

   www.aol.com/2012/11/03/how-do-you-solve-a...

   For premium support please call: 800-290-4726 more ways to reach us

9. 6 popular herbal supplements linked to potential liver risks

   www.aol.com/lifestyle/6-popular-herbal...

   Researchers at the University of Michigan report that an estimated 15.6 million U.S. adults — or 5% — have taken at least one herbal supplement in the last 30 days that might be damaging to ...